Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoView Biosciences developed the ExoView platform, a fully automated, chip-based technology for high-resolution, label-free analysis of exosomes and other extracellular vesicles. The technology is widely used in research labs for EV size distribution, phenotyping, titer, and biomarker studies, including immuno-oncology and cell therapy applications. NanoView was acquired in 2022 by Unchained Labs; clinical study results are not applicable as the technology is for research use only.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoView Biosciences.